Axial Spondyloarthritis Market Forecast 2022-2032: Types, Drug Classes, and Regional Insights
The Global Axial Spondyloarthritis (axSpA) Market Size is expected to reach USD 10.1 billion by 2032, at a CAGR of 6.86% during the forecast period 2022 to 2032. However, with continued advancements in research and development, increasing awareness, and improving access to treatment, the market is expected to grow over the long term.